Biological and Medicinal Chemistry

Repurposing Therapeutics for COVID-19: Supercomputer-Based Docking to the SARS-CoV-2 Viral Spike Protein and Viral Spike Protein-Human ACE2 Interface

Authors

Abstract

The novel Wuhan coronavirus (SARS-CoV-2) has been sequenced, and the virus shares substantial similarity with SARS-CoV. Here, using a computational model of the spike protein (S-protein) of SARS-CoV-2 interacting with the human ACE2 receptor, we make use of the world's most powerful supercomputer, SUMMIT, to enact an ensemble docking virtual high-throughput screening campaign and identify small-molecules which bind to either the isolated Viral S-protein at its host receptor region or to the S protein-human ACE2 interface. We hypothesize the identified small-molecules may be repurposed to limit viral recognition of host cells and/or disrupt host-virus interactions. A ranked list of compounds is given that can be tested experimentally.

Version notes

Version 3. Updated compression of gzipped-tarball and cleaned directory tree within SI to make it easier to use.

Content

Thumbnail image of coronavirus_jcs_mds_withS-OnlyAdded_v3_FixedVirusNaming_SecondUploadToChemxriv.pdf

Supplementary material

Thumbnail image of SI_updated.tar.tgz
SI updated.tar